Development of congenic strains of mice carrying amyloidogenic apolipoprotein A-II (Apoa2c). Apoa2c reduces the plasma level and the size of high density lipoprotein

FEBS Lett. 1993 Feb 15;317(3):207-10. doi: 10.1016/0014-5793(93)81277-7.

Abstract

A congenic strain of mice with amyloidogenic apolipoprotein A-II (Apoa2c) on the genetic background of the amyloidosis-resistant SAM-R/1 strain was produced by 12 generations of backcrossing. Genome mapping using endogenous murine leukemia proviral markers was done in the congenic strain, termed R1.P1-Apoa2c. We confirmed that only a small region surrounding the apoA-II gene on chromosome 1 was transferred from the genome of the donor SAM-P/1 strain. The level and particle size of plasma high density lipoprotein were decreased in R1.P1-Apoa2c mice compared to those in the progenitor SAM-R/1 mice. The function of apoA-II can be studied using this strain of mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis / genetics
  • Animals
  • Apolipoprotein A-II / analogs & derivatives*
  • Apolipoprotein A-II / genetics
  • Apolipoprotein A-II / physiology
  • Chromosome Mapping / veterinary
  • Crosses, Genetic
  • Female
  • Genetic Markers
  • Leukemia Virus, Murine / genetics
  • Lipoproteins, HDL / blood*
  • Lipoproteins, HDL / chemistry
  • Male
  • Mice
  • Mice, Inbred Strains / blood
  • Mice, Inbred Strains / genetics*
  • Proviruses / genetics

Substances

  • Apolipoprotein A-II
  • Genetic Markers
  • Lipoproteins, HDL
  • amyloidogenic apolipoprotein A-II, mouse